Tag Archives | MNCH

Mapping the Financial Flow and Expenditures for Select MNCH Medicines in Uganda

Since the report of the United Nations Commission on Life-saving Commodities for Women and Children (UNCoLSC) was published in 2012, much has been done to highlight the challenges countries face in ensuring the availability of essential commodities and to create resources to assist countries in this endeavor. In most settings, these commodities are procured with government funds, but there is a lack of documented evidence as to how decisions regarding financing for these commodities are made and executed. An understanding of the financial flows for MNCH commodities is critical as countries pursue the goals of ending preventable child and maternal deaths and of universal health coverage and as many go through processes of decentralization. Understanding financial flows for MNCH commodities may also assist the donor community in making smarter investments and assisting countries in mobilizing additional resources. The US Agency for International Development (USAID) commissioned this study in Bangladesh, Nepal, Kenya, and Uganda.

Read full story · Comments are closed

Mapping the Financial Flow and Expenditures for Select MNCH Medicines in Kenya

Since the report of the United Nations Commission on Life-Saving Commodities for Women and Children (UNCoLSC) was published in 2012, much has been done to highlight the challenges countries face in ensuring the availability of essential commodities and to create resources to assist countries in this endeavor. In most settings, these commodities are procured with government funds, but there is a lack of documented evidence as to how decisions regarding financing for these commodities are made and executed. An understanding of the financial flows for MNCH commodities is critical as countries pursue the goals of ending preventable child and maternal deaths and of universal health coverage and as many go through the process of decentralization. Understanding financial flows for MNCH commodities may also assist the donor community in making smarter investments and assisting countries in mobilizing additional resources. SIAPS conducted an assessment of subnational procurement practices in Kenya. One component of that assessment is related to understanding the financial flows for MNCH commodities.

Read full story · Comments are closed

Mapping the Financial Flow and Expenditures for Select MNCH Medicines in Bangladesh

Since the report of the United Nations Commission on Life-saving Commodities for Women and Children (UNCoLSC) was published in 2012, much has been done to highlight the challenges countries face in ensuring the availability of essential commodities and to create resources to assist countries in this endeavor. In most settings, these commodities are procured with government funds, but there is a lack of documented evidence as to how decisions regarding financing for these commodities are made and executed. An understanding of the financial flows for MNCH commodities is critical as countries pursue the goals of ending preventable child and maternal deaths and of universal health coverage and as many go through processes of decentralization. Understanding financial flows for MNCH commodities may also assist the donor community in making smarter investments and assisting countries in mobilizing additional resources. The US Agency for International Development (USAID) commissioned this study in Bangladesh, Nepal, Kenya, and Uganda.

Read full story · Comments are closed

Challenges to Ensuring Adequate and Timely Funding for MNCH Commodities

As countries pursue the maternal, newborn, and child health (MNCH) targets established under Sustainable Development Goal 3, they will need to ensure the continuous availability of essential health commodities to prevent and treat the conditions that cause morbidity and mortality in those groups. Since the report of the United Nations Commission on Life-Saving Commodities for Women and Children (UNCoLSC) was published in 2012, much progress has been made to highlight the challenges countries face in ensuring access to essential commodities and to create resources to overcome these challenges. A major issue yet to be adequately addressed is financing for these life-saving commodities. SIAPS mapped the budget allocation, approval, disbursement, and reporting processes in the public sector for essential MNCH commodities in four countries—
Bangladesh, Kenya, Nepal, and Uganda—to inform the development of strategies and
interventions that will improve access to these commodities.

Read full story · Comments are closed

Assessing Sub-National Procurement Practices of Maternal, Newborn, and Child Health Commodities in Kenya

The SIAPS Program works at both the global and country levels to improve pharmaceutical management systems that increase access to quality medicines. SIAPS has developed a methodology to assess sub-national procurement practices. This methodology was used in Kenya to assess county-level procurement practices for essential maternal, newborn, and child health (MNCH) commodities and to study the availability of essential MNCH commodities. The information gathered was used to generate recommendations to strengthen local procurement practices and overall procurement strategies.

Read full story · Comments are closed

Guidance on Elements to Consider when Planning for the Integration of Oxytocin into the EPI Cold Chain

The purpose of this document is to provide guidance to national program managers who are considering integrating oxytocin into the EPI cold chain. It is intended for representatives from relevant offices of the Ministry of Health (MoH), such as Pharmacy, Central Medical Stores, and Maternal and Child Health, as well as other policy makers, stakeholders, and implementing partners.

This guidance document introduces the pharmaceutical management elements that must be considered to successfully integrate oxytocin into the EPI cold chain and outlines the steps that will help national program managers plan the integration processes and strategies. Integrating oxytocin into the EPI cold chain may affect several elements within the pharmaceutical management cycle, from distribution systems, inventory management, and logistics management information systems and reporting procedures to roles and responsibilities, health facility infrastructure, and monitoring and evaluation. Some elements of the pharmaceutical system are afterthoughts that are only considered when challenges arise during implementation. Taking into account all elements that will be impacted by integrating oxytocin into a supply chain will not only help identify issues but also address needed changes in standard operating procedures and at the various stages of the supply chain. It is important to consider each element and address it in the strategy and implementation plan to ensure that oxytocin integration into the EPI cold chain is successful.

Read full story · Comments are closed